{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:35:06Z","timestamp":1776285306463,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T00:00:00Z","timestamp":1464048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1208\/s12249-016-0553-8","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T20:22:49Z","timestamp":1464121369000},"page":"710-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Surface-Modified Liposomal Formulation of Amphotericin B: In vitro Evaluation of Potential Against Visceral Leishmaniasis"],"prefix":"10.1208","volume":"18","author":[{"given":"Shilpa N.","family":"Patere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj O.","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kumar Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash","family":"Kumar Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miten J.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand G.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Gota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mangal S.","family":"Nagarsenker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,24]]},"reference":[{"issue":"2","key":"553_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00436-012-2868-z","volume":"111","author":"N Shakya","year":"2012","unstructured":"Shakya N, Sane SA, Haq W. Augmentation of anti-leishmanial efficacy of miltefosine in combination with tuftsin against experimental visceral leishmaniasis. Parasitol Res. 2012;111(2):563\u201370.","journal-title":"Parasitol Res"},{"key":"553_CR2","first-page":"163","volume-title":"Tropical and emerging infectious diseases","author":"HC Maltezou","year":"2010","unstructured":"Maltezou HC. Leishmaniasis. In: Maltezou HC, Gikas A, editors. Tropical and emerging infectious diseases. Kerala: Research Signpost; 2010. p. 163\u201385."},{"issue":"11","key":"553_CR3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","volume":"19","author":"SL Croft","year":"2003","unstructured":"Croft SL, Coombs GH. Leishmaniasis\u2014current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 2003;19(11):502\u20138.","journal-title":"Trends Parasitol"},{"issue":"34","key":"553_CR4","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1016\/j.biomaterials.2013.07.068","volume":"34","author":"O Molavi","year":"2013","unstructured":"Molavi O, Xiong X, Douglas D, Kneteman N, Nagata S, Pastan I, et al. Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma. Biomaterials. 2013;34(34):8718\u201325.","journal-title":"Biomaterials"},{"issue":"12","key":"553_CR5","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.biomaterials.2013.01.039","volume":"34","author":"K Joo","year":"2013","unstructured":"Joo K, Xiao L, Liu S, Liu Y, Lee C, Conti PS, et al. Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs. Biomaterials. 2013;34(12):3098\u2013109.","journal-title":"Biomaterials"},{"issue":"1\u20133","key":"553_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbiotec.2004.06.007","volume":"113","author":"RH Muller","year":"2004","unstructured":"Muller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs\u2014a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol. 2004;113(1\u20133):151\u201370.","journal-title":"J Biotechnol"},{"issue":"1\u20132","key":"553_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00522-6","volume":"210","author":"SP Vyas","year":"2000","unstructured":"Vyas SP, Katare YK, Mishra V, Sihorkar V. Ligand directed macrophage targeting of amphotericin B loaded liposomes. Int J Pharm. 2000;210(1\u20132):1\u201314.","journal-title":"Int J Pharm"},{"issue":"1","key":"553_CR8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpb.2005.07.004","volume":"62","author":"S Wang","year":"2006","unstructured":"Wang S, Deng Y, Xu H, Wu H, Qiu Y, Chen D. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin. Eur J Pharm Biopharm. 2006;62(1):32\u20138.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"553_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2004.08.021","volume":"287","author":"Y Higuchi","year":"2004","unstructured":"Higuchi Y, Nishikawa M, Kawakami S, Yamashita F, Hashida M. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and kupffer cells. Int J Pharm. 2004;287(1\u20132):147\u201354.","journal-title":"Int J Pharm"},{"issue":"9","key":"553_CR10","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood.V80.9.2363.bloodjournal8092363","volume":"80","author":"N Harris","year":"1992","unstructured":"Harris N, Super M, Rits M, Chang G, Ezekowitz RA. Characterization of murine macrophage mannose receptor: demonstration that the downregulation of receptor expression mediated by interferon-gamma occurs at the level of transcription. Blood. 1992;80(9):2363\u201373.","journal-title":"Blood"},{"issue":"11","key":"553_CR11","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V78.11.2900.2900","volume":"78","author":"SD Blystone","year":"1991","unstructured":"Blystone SD, Weston LK, Kaplan JE. Fibronectin dependent macrophage fibrin binding. Blood. 1991;78(11):2900\u20137.","journal-title":"Blood"},{"issue":"5","key":"553_CR12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0142-9612(01)00251-4","volume":"23","author":"T Ehrenfreund-Kleinman","year":"2002","unstructured":"Ehrenfreund-Kleinman T, Azzam T, Falk R, Polacheck I, Golenser J, Domb AJ. Synthesis and characterization of novel water soluble amphotericin B\u2013arabinogalactan conjugates. Biomaterials. 2002;23(5):1327\u201335.","journal-title":"Biomaterials"},{"issue":"2","key":"553_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.1999.61.193","volume":"61","author":"V Yardley","year":"1999","unstructured":"Yardley V, Croft SL. In vitro and in vivo activity of amphotericin B lipid formulations against experimental Trypanosoma cruzi infections. Am J Trop Med Hyg. 1999;61(2):193\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"553_CR14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.trstmh.2010.08.010","volume":"104","author":"KD Corware","year":"2010","unstructured":"Corware KD, Rogers M, Teo I, Muller I, Shaunak S. An amphotericin B-based drug for treating experimental Leishmania major infection. Trans R Soc Trop Med Hyg. 2010;104(11):749\u201350.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9","key":"553_CR15","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.addr.2013.05.007","volume":"65","author":"B Lepenies","year":"2013","unstructured":"Lepenies B, Lee J, Sonkaria S. Targeting C-type lectin receptors with multivalent carbohydrate ligands. Adv Drug Deliv Rev. 2013;65(9):1271\u201381.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"553_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","volume":"53","author":"SM Moghimi","year":"2001","unstructured":"Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283\u2013318.","journal-title":"Pharmacol Rev"},{"issue":"8","key":"553_CR17","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1073\/pnas.77.8.4430","volume":"77","author":"MR Mauk","year":"1980","unstructured":"Mauk MR, Gamble RC, Baldeschwieler JD. Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leucocytes in mice. Proc Natl Acad Sci U S A. 1980;77(8):4430\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"553_CR18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.gt.3301089","volume":"7","author":"S Kawakami","year":"2000","unstructured":"Kawakami S, Sato A, Nishikawa M, Yamashita F, Hashida M. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. 2000;7(4):292\u20139.","journal-title":"Gene Ther"},{"issue":"15","key":"553_CR19","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.carres.2009.06.025","volume":"344","author":"T Salomonsen","year":"2009","unstructured":"Salomonsen T, Jensen HM, Larsen FH, Steuernagel S, Engelsen SB. Direct quantification of M\/G ratio from 13C CP-MAS NMR spectra of alginate powders by multivariate curve resolution. Carbohydr Res. 2009;344(15):2014\u201322.","journal-title":"Carbohydr Res"},{"issue":"1","key":"553_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0250-474X.89757","volume":"73","author":"MP Jadhav","year":"2011","unstructured":"Jadhav MP, Nagarsenker MS, Gaikwad RV, Samad A, Kshirsagar NA. Formulation and evaluation of long circulating liposomal amphotericin B: a scinti-kinetic study using Tc in BALB\/C mice. Indian J Pharm Sci. 2011;73(1):57\u201364.","journal-title":"Indian J Pharm Sci"},{"key":"553_CR21","unstructured":"Pathak PO. Design, optimization and evaluation of novel lipid based particulate carriers for chemotherapeutic agents. Dissertation, 2012; Mumbai University."},{"issue":"4","key":"553_CR22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nano.2011.07.002","volume":"8","author":"D Singodia","year":"2012","unstructured":"Singodia D, Verma A, Verma RK, Mishra PR. Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulphated N-acetyl galactosamine more efficiently in comparison with mannose decorated liposomes: an application in drug delivery. Nanomedicine. 2012;8(4):468\u201377.","journal-title":"Nanomedicine"},{"issue":"13","key":"553_CR23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng P, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82(13):1107\u201312.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"553_CR24","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","volume":"1","author":"V Vichai","year":"2006","unstructured":"Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112\u20136.","journal-title":"Nat Protoc"},{"issue":"6","key":"553_CR25","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.35.6.1208","volume":"35","author":"RM Fielding","year":"1991","unstructured":"Fielding RM, Smith PC, Wang LH, Porter J, Guo LS. Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats. Antimicrob Agents Chemother. 1991;35(6):1208\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"553_CR26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.aca.2008.12.006","volume":"634","author":"JL Italia","year":"2009","unstructured":"Italia JL, Singh D, Ravi Kumar MNV. High-performance liquid chromatographic analysis of amphotericin B in rat plasma using \u03b1- naphthol as an internal standard. Anal Chim Acta. 2009;634(1):110\u20134.","journal-title":"Anal Chim Acta"},{"issue":"5","key":"553_CR27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.41.5.972","volume":"41","author":"D Sereno","year":"1997","unstructured":"Sereno D, Lemesre JL. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chemother. 1997;41(5):972\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"553_CR28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11010-011-0762-0","volume":"352","author":"AK Shukla","year":"2011","unstructured":"Shukla AK, Patra S, Dubey VK. Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis. Mol Cell Biochem. 2011;352(1\u20132):261\u201370.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"553_CR29","first-page":"279","volume":"5","author":"BG Davis","year":"2002","unstructured":"Davis BG, Robinson MA. Drug delivery systems based on sugar-macromolecule conjugates. Curr Opin Drug Discov Devel. 2002;5(2):279\u201388.","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"6","key":"553_CR30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","volume":"59","author":"AA Date","year":"2007","unstructured":"Date AA, Joshi MD, Patravale VB. Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev. 2007;59(6):505\u201321.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"553_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0005-2736(92)90084-Y","volume":"1109","author":"AT Horowitz","year":"1992","unstructured":"Horowitz AT, Barenholz Y, Gabizon AA. In vitro cytotoxicity of liposome encapsulated doxorubicin: dependence on liposome composition and drug release. Biochim Biophys Acta. 1992;1109(2):203\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"553_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.lfs.2003.12.020","volume":"75","author":"C Carrion","year":"2004","unstructured":"Carrion C, de Madariaga MA, Domingo JC. In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells. Life Sci. 2004;75(3):313\u201328.","journal-title":"Life Sci"},{"issue":"5","key":"553_CR33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejps.2010.05.005","volume":"40","author":"JP Jain","year":"2010","unstructured":"Jain JP, Kumar N. Development of amphotericin B loaded polymersomes based on (PEG)3-PLA co-polymers: factors affecting size and in vitro evaluation. Eur J Pharm Sci. 2010;40(5):456\u201365.","journal-title":"Eur J Pharm Sci"},{"issue":"18","key":"553_CR34","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1242\/jcs.112.18.2993","volume":"112","author":"J Alexander","year":"1999","unstructured":"Alexander J, Satoskar AR, Russell DG. Leishmania species: models of intracellular parasitism. J Cell Sci. 1999;112(18):2993\u20133002.","journal-title":"J Cell Sci"},{"issue":"1","key":"553_CR35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/dkm396","volume":"61","author":"A Banerjee","year":"2008","unstructured":"Banerjee A, Roychoudhury J, Ali N. Stearylamine bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine. J Antimicrob Chemother. 2008;61(1):103\u201310.","journal-title":"J Antimicrob Chemother"},{"issue":"23","key":"553_CR36","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1021\/bi00237a011","volume":"30","author":"J Bolard","year":"1991","unstructured":"Bolard J, Legrand P, Heitz F, Cybulska B. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry. 1991;30(23):5707\u201315.","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"553_CR37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.05.013","volume":"361","author":"R Espada","year":"2008","unstructured":"Espada R, Valdespina S, Alfonso C, Rivas G, Ballesteros MP, Torrado JJ. Effect of aggregation state on the toxicity of different amphotericin B preparations. Int J Pharm. 2008;361(1\u20132):64\u20139.","journal-title":"Int J Pharm"},{"issue":"6","key":"553_CR38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/BF02716840","volume":"6","author":"D Pain","year":"1984","unstructured":"Pain D, Das PK, Ghosh P, Bachhawat BK. Increased circulatory half-life of liposomes after conjugation with dextran. J Biosci. 1984;6(6):811\u20136.","journal-title":"J Biosci"},{"issue":"1","key":"553_CR39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-2952(87)90387-X","volume":"36","author":"RG Melton","year":"1987","unstructured":"Melton RG, Wiblin CN, Foster RL, Sherwood RF. Covalent linkage of carboxypeptidase G2 to soluble dextrans\u2014I. Properties of conjugates and effects on plasma persistance in mice. Biochem Pharmacol. 1987;36(1):105\u201312.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"553_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-2952(87)90388-1","volume":"36","author":"RG Melton","year":"1987","unstructured":"Melton RG, Wiblin CN, Baskerville A, Foster RL, Sherwood RF. Covalent linkage of carboxypeptidase G2 to soluble dextrans\u2014I. In vivo distribution and fate of conjugates. Biochem Pharmacol. 1987;36(1):113\u201321.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"553_CR41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0169-409X(91)90039-F","volume":"6","author":"TE Wileman","year":"1991","unstructured":"Wileman TE. Properties of asparaginase-dextran conjugates. Adv Drug Deliv Rev. 1991;6(2):167\u201380.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"553_CR42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/088391159701200102","volume":"12","author":"EC Kang","year":"1997","unstructured":"Kang EC, Akiyoshi K, Sunamoto J. Surface coating of liposomes with hydrophobized polysaccharides. J Bioact Compat Polym. 1997;12(1):14\u201326.","journal-title":"J Bioact Compat Polym"},{"issue":"1","key":"553_CR43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/dkp140","volume":"64","author":"P Gershkovich","year":"2009","unstructured":"Gershkovich P, Wasan EL, Lin M, Sivak O, Leon CG, Clement JG, et al. Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation. J Antimicrob Chemother. 2009;64(1):101\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"553_CR44","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/jps.2600830716","volume":"83","author":"KM Wasan","year":"1994","unstructured":"Wasan KM, Mortan RE, Rosenblum MG, Lopez-Berestein G. Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high density lipoproteins: role of lipid transfer protein. J Pharm Sci. 1994;83(7):1006\u201310.","journal-title":"J Pharm Sci"},{"issue":"1","key":"553_CR45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/dkl177","volume":"58","author":"MA Khan","year":"2006","unstructured":"Khan MA, Owais M. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. J Antimicrob Chemother. 2006;58(1):125\u201332.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"553_CR46","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/AAC.44.4.898-904.2000","volume":"44","author":"I Echevarria","year":"2000","unstructured":"Echevarria I, Barturen C, Renedo MJ, Troconiz IF, Carmen Dios-Vieitez M. Comparative pharmacokinetics, tissue distributions and effects on renal function of novel polymeric formulations of amphotericin B and amphotericin B deoxycholate in rats. Antimicrob Agents Chemother. 2000;44(4):898\u2013904.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"553_CR47","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1023\/A:1007605024942","volume":"17","author":"I Bekersky","year":"2000","unstructured":"Bekersky I, Boswell GW, Hiles R, Fielding RM, Buell D, Walsh TJ. Safety, toxicokinetics, and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats. Pharm Res. 2000;17(12):1494\u2013502.","journal-title":"Pharm Res"},{"key":"553_CR48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-662-22115-0_15","volume-title":"Long-circulating liposomes: old drugs, new therapeutics","author":"RM Fielding","year":"1998","unstructured":"Fielding RM, Mukwaya G, Sandhaus RA. Clinical and preclinical studies with low-clearance liposomal amikacin (MiKasome). In: Woodle MC, Storm G, editors. Long-circulating liposomes: old drugs, new therapeutics. Georgetown: Springer-Verlag and Landes Bioscience; 1998. p. 213\u201325."},{"issue":"1\u20132","key":"553_CR49","first-page":"45","volume":"32","author":"HM Patel","year":"1998","unstructured":"Patel HM, Moghimi SM. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system\u2014the concept of tissue specificity. Adv Drug Deliv Rev. 1998;32(1\u20132):45\u201360.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"553_CR50","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/AAC.44.6.1739-1742.2000","volume":"44","author":"T Dey","year":"2000","unstructured":"Dey T, Anam K, Afrin F, Ali N. Antileishmanial activities of stearylamine bearing liposomes. Antimicrob Agents Chemother. 2000;44(6):1739\u201342.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-016-0553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-016-0553-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-016-0553-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-016-0553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:15:53Z","timestamp":1748978153000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-016-0553-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,24]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["553"],"URL":"https:\/\/doi.org\/10.1208\/s12249-016-0553-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,24]]}}}